TrialEpilepsia2020

Efficacy and safety of adjunctive perampanel 4 mg/d for the treatment of focal seizures: A pooled post hoc analysis of four randomized, double-blind, phase III studies.

Bernhard J Steinhoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.